Annual Drug Patent Expirations for PEDMARK
Pedmark is a drug marketed by Fennec Pharms Inc and is included in one NDA. There are two patents protecting this drug.
This drug has thirty-three patent family members in twelve countries.
The generic ingredient in PEDMARK is sodium thiosulfate. Additional details are available on the sodium thiosulfate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com